Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Reexamination Certificate
2003-10-21
2008-08-19
Li, Q. Janice (Department: 1633)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
C424S093100, C424S093200
Reexamination Certificate
active
07413733
ABSTRACT:
A delivery system comprising a T cell comprising at least one antigen capable of loading antigen-presenting-cells with the antigen.
REFERENCES:
patent: 4663058 (1987-05-01), Wells et al.
patent: 5139941 (1992-08-01), Muzyczka et al.
patent: 5797368 (1998-08-01), Kreuter et al.
patent: 0 904 786 (1999-03-01), None
patent: 0 905 786 (1999-03-01), None
patent: 1 148 066 (2001-10-01), None
patent: WO 95/31208 (1995-11-01), None
patent: WO 96/01126 (1996-01-01), None
patent: WO 97/19169 (1997-05-01), None
Strobel et al, Hum Gene Ther 2000;11:2207-18.
McWilliams et al, J Immunol 2006;177:155-61.
Powell et al, J Immunol 2006; 177(9):6527-39.
Yu & Restifo, J Clin Invest Aug. 2002;110:289-94.
Bodey et al, Anticancer Res 2000;20:2665-76.
Janeway et al, Immunobiol 2001, see Particularly Part IV,§ 8.
Cebon et al, Austral J Dermatol 1997;58:S66-72.
Mathisen et al., Brief Definitive Report; Treatment of Experimental Autoimmune Encephalomyelitis With Genetically Modified Memory T Cells; vol. 186, No. 1, Jul. 7, 1997; pp. 159-164.
WPIDS Abstract Accession No. 2003-046799/200304 and Related Publication Jan. 2007. WO 2002/079253A; Cancer Antigen WTI Modified Peptides and DNA Encoding Them For Cancer Immunotherapy; Inventor: H. Sugiyama; Oct. 2004.
Bordignon et al.,Haematologica, 84(12):1110-1149 (1999).
International Search Report in PCT/IB03/05109 dated Mar. 1, 2004.
Introna et al.,Hum. Gene Ther.,11(4):611-620 (2000).
Riddell et al.,Nat. Med., 2(2):216-223 (1996).
Verzeletti et al.,Hum. Gene Ther., 9(15):2243-2251 (1998).
Yang et al.,J. Virol.,69(4):2004-2015 (1995).
Bordignon Claudio
Traversari Catia
Li Q. Janice
Marshall & Gerstein & Borun LLP
MolMed SpA
LandOfFree
Antigen transduced T cells used as a delivery system for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antigen transduced T cells used as a delivery system for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antigen transduced T cells used as a delivery system for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4014354